JP2007500753A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500753A5 JP2007500753A5 JP2006533722A JP2006533722A JP2007500753A5 JP 2007500753 A5 JP2007500753 A5 JP 2007500753A5 JP 2006533722 A JP2006533722 A JP 2006533722A JP 2006533722 A JP2006533722 A JP 2006533722A JP 2007500753 A5 JP2007500753 A5 JP 2007500753A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- formula
- heterocycle
- hydroxyalkyl
- absent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/459,925 | 2003-06-12 | ||
| US10/459,925 US7015233B2 (en) | 2003-06-12 | 2003-06-12 | Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| US10/864,068 | 2004-06-09 | ||
| US10/864,068 US7375126B2 (en) | 2003-06-12 | 2004-06-09 | Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| PCT/US2004/018590 WO2004111009A1 (en) | 2003-06-12 | 2004-06-10 | Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011049274A Division JP2011153148A (ja) | 2003-06-12 | 2011-03-07 | バニロイド受容体サブタイプ１（ｖｒ１）受容体を阻害する縮合化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007500753A JP2007500753A (ja) | 2007-01-18 |
| JP2007500753A5 true JP2007500753A5 (enExample) | 2011-04-28 |
| JP4857113B2 JP4857113B2 (ja) | 2012-01-18 |
Family
ID=33555102
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533722A Expired - Fee Related JP4857113B2 (ja) | 2003-06-12 | 2004-06-10 | バニロイド受容体サブタイプ１（ｖｒ１）受容体を阻害する融合化合物 |
| JP2011049274A Pending JP2011153148A (ja) | 2003-06-12 | 2011-03-07 | バニロイド受容体サブタイプ１（ｖｒ１）受容体を阻害する縮合化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011049274A Pending JP2011153148A (ja) | 2003-06-12 | 2011-03-07 | バニロイド受容体サブタイプ１（ｖｒ１）受容体を阻害する縮合化合物 |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1658269B1 (enExample) |
| JP (2) | JP4857113B2 (enExample) |
| KR (2) | KR101138216B1 (enExample) |
| CN (1) | CN102617464A (enExample) |
| AT (2) | ATE510824T1 (enExample) |
| AU (2) | AU2004247721C1 (enExample) |
| BR (1) | BRPI0411116A (enExample) |
| CA (2) | CA2756058A1 (enExample) |
| CY (2) | CY1108713T1 (enExample) |
| DE (1) | DE602004017329D1 (enExample) |
| DK (2) | DK2017265T3 (enExample) |
| ES (1) | ES2318308T3 (enExample) |
| IL (4) | IL172457A (enExample) |
| MX (1) | MXPA05013550A (enExample) |
| NZ (3) | NZ543713A (enExample) |
| PL (2) | PL2017265T3 (enExample) |
| PT (2) | PT2017265E (enExample) |
| SI (2) | SI2017265T1 (enExample) |
| TW (3) | TWI366461B (enExample) |
| WO (1) | WO2004111009A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050026844A1 (en) | 2003-04-03 | 2005-02-03 | Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
| EP1765311A4 (en) | 2004-03-16 | 2009-04-29 | Univ California | REDUCTION OF NEPHROPATHY WITH INHIBITORS OF SOLUBLE EPOXY HYDROLASE AND EPOXYEICOSANOIDS |
| AU2005295167B2 (en) | 2004-10-20 | 2012-05-10 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| EP1824843A2 (en) | 2004-12-07 | 2007-08-29 | Locus Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| CA2589271A1 (en) | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
| AP2008004432A0 (en) | 2005-10-07 | 2008-04-30 | Glenmark Pharmaceuticals Sa | Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| CA2626579A1 (en) * | 2005-10-25 | 2007-05-03 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
| CN101365684A (zh) * | 2005-10-28 | 2009-02-11 | 艾博特公司 | 抑制trpv1受体的吲唑衍生物 |
| TW200808723A (en) | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| EP2012778A4 (en) * | 2006-04-18 | 2011-08-10 | Abbott Lab | VANILLOID RECEPTOR (VR1) SUBType 1 ANTAGONISTS AND USES THEREOF |
| WO2009081222A1 (en) | 2007-12-21 | 2009-07-02 | Glenmark Pharmaceuticals, S.A. | Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| JP5643112B2 (ja) | 2008-01-28 | 2014-12-17 | アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ | バニロイド受容体としての新規化合物、その異性体または薬剤学的に許容し得る塩、及びこれを含有する医薬組成物 |
| JP5438103B2 (ja) | 2008-07-02 | 2014-03-12 | アモーレパシフィック コーポレイション | バニロイド受容体アンタゴニストとしての新規化合物、その異性体またはその薬学的に許容される塩、並びにそれを含む医薬組成物 |
| UY32180A (es) * | 2008-10-17 | 2010-05-31 | Abbott Lab | Antagonistas del receptor transitorio potencial de vanilloides 1 (trpv1) |
| US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| MY173181A (en) | 2011-05-13 | 2020-01-02 | Array Biopharma Inc | Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors |
| US9375005B2 (en) * | 2012-05-09 | 2016-06-28 | Bayer Cropscience Ag | 5-halogenopyrazole indanyl carboxamides |
| US9822118B2 (en) | 2012-11-13 | 2017-11-21 | Array Biopharma Inc. | Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| EP2922844B1 (en) | 2012-11-13 | 2018-01-10 | Array Biopharma, Inc. | N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| WO2014078331A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| US9809578B2 (en) | 2012-11-13 | 2017-11-07 | Array Biopharma Inc. | Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors |
| US9981959B2 (en) | 2012-11-13 | 2018-05-29 | Array Biopharma Inc. | Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| WO2014078378A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| EP2920166B1 (en) | 2012-11-13 | 2016-11-02 | Array Biopharma, Inc. | Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain |
| WO2014078325A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| US9790178B2 (en) | 2012-11-13 | 2017-10-17 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| WO2014078328A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| LT3154959T (lt) | 2014-05-15 | 2019-09-25 | Array Biopharma, Inc. | 1-((3s,4r)-4-(3-fluorfenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)karbamidas kaip trka kinazės inhibitorius |
| WO2017190107A1 (en) * | 2016-04-29 | 2017-11-02 | Board Of Regents, The University Of Texas System | Sigma receptor binders |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW536734B (en) * | 2000-07-31 | 2003-06-11 | Clariant Int Ltd | Process for manufacturing a microelectronic device |
| WO2003014064A1 (en) * | 2001-07-31 | 2003-02-20 | Bayer Healthcare Ag | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| JP2003192587A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
| CA2476936A1 (en) * | 2002-02-20 | 2003-08-28 | Chih-Hung Lee | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| GB0206876D0 (en) * | 2002-03-22 | 2002-05-01 | Merck Sharp & Dohme | Therapeutic agents |
| US6984647B2 (en) * | 2002-05-17 | 2006-01-10 | Janssen Pharmaceutica N.V. | Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
-
2004
- 2004-06-10 DE DE602004017329T patent/DE602004017329D1/de not_active Expired - Lifetime
- 2004-06-10 EP EP04754996A patent/EP1658269B1/en not_active Expired - Lifetime
- 2004-06-10 SI SI200431715T patent/SI2017265T1/sl unknown
- 2004-06-10 NZ NZ543713A patent/NZ543713A/en not_active IP Right Cessation
- 2004-06-10 ES ES04754996T patent/ES2318308T3/es not_active Expired - Lifetime
- 2004-06-10 CA CA2756058A patent/CA2756058A1/en not_active Abandoned
- 2004-06-10 JP JP2006533722A patent/JP4857113B2/ja not_active Expired - Fee Related
- 2004-06-10 WO PCT/US2004/018590 patent/WO2004111009A1/en not_active Ceased
- 2004-06-10 NZ NZ590234A patent/NZ590234A/en not_active IP Right Cessation
- 2004-06-10 KR KR1020057023829A patent/KR101138216B1/ko not_active Expired - Fee Related
- 2004-06-10 CA CA2526872A patent/CA2526872C/en not_active Expired - Fee Related
- 2004-06-10 PT PT08166079T patent/PT2017265E/pt unknown
- 2004-06-10 DK DK08166079.7T patent/DK2017265T3/da active
- 2004-06-10 EP EP08166079A patent/EP2017265B1/en not_active Expired - Lifetime
- 2004-06-10 NZ NZ578264A patent/NZ578264A/en not_active IP Right Cessation
- 2004-06-10 SI SI200430995T patent/SI1658269T1/sl unknown
- 2004-06-10 AU AU2004247721A patent/AU2004247721C1/en not_active Ceased
- 2004-06-10 CN CN2012100573625A patent/CN102617464A/zh active Pending
- 2004-06-10 DK DK04754996T patent/DK1658269T3/da active
- 2004-06-10 PL PL08166079T patent/PL2017265T3/pl unknown
- 2004-06-10 AT AT08166079T patent/ATE510824T1/de active
- 2004-06-10 PL PL04754996T patent/PL1658269T3/pl unknown
- 2004-06-10 AT AT04754996T patent/ATE411982T1/de active
- 2004-06-10 BR BRPI0411116-8A patent/BRPI0411116A/pt not_active IP Right Cessation
- 2004-06-10 KR KR1020117017610A patent/KR101150324B1/ko not_active Expired - Fee Related
- 2004-06-10 MX MXPA05013550A patent/MXPA05013550A/es active IP Right Grant
- 2004-06-10 PT PT04754996T patent/PT1658269E/pt unknown
- 2004-06-14 TW TW099119548A patent/TWI366461B/zh not_active IP Right Cessation
- 2004-06-14 TW TW101107398A patent/TW201300361A/zh unknown
- 2004-06-14 TW TW093117059A patent/TWI394569B/zh not_active IP Right Cessation
-
2005
- 2005-12-08 IL IL172457A patent/IL172457A/en not_active IP Right Cessation
-
2009
- 2009-01-14 CY CY20091100044T patent/CY1108713T1/el unknown
-
2010
- 2010-08-01 IL IL207335A patent/IL207335A/en not_active IP Right Cessation
- 2010-12-17 AU AU2010257277A patent/AU2010257277B2/en not_active Ceased
-
2011
- 2011-03-07 JP JP2011049274A patent/JP2011153148A/ja active Pending
- 2011-07-28 CY CY20111100738T patent/CY1111945T1/el unknown
- 2011-10-27 IL IL215997A patent/IL215997A0/en unknown
- 2011-10-30 IL IL216046A patent/IL216046A0/en unknown